Welcome back to High Leverage Outlier, PHE’s bimonthly newsletter. I’m Carolyn Harley, General Manager.
In this edition, we’re excited to highlight our upcoming webinar on patient-centered research, as well as recent PHE studies and insights – ranging from our ASCO presentation on the negative impacts of access delays for CAR-T treatments to published evidence linking reductions in cancer care spending to lower survival.
Please join us for our upcoming live webinar on July 25th at 10:00 AM PT.
“The Science of Dialogue: Patient-centered Value Assessment” will be presented by Associate Director Suepattra May-Slater, PhD, MPH, a medical anthropologist, and Scientific Advisor Katharine Batt, MD, an oncologist/hematologist.
Dr. Julia Snider’s research on the impact of delays in patient access to new CAR-T therapies for patients with pediatric lymphoma gained substantial media attention at ASCO’s 2018 annual conference, [including from HemOnc Today and the Journal of Clinical Pathways]. High Leverage Outlier sits down with Dr. Snider to discuss the importance of this study.
PHE’s Jason Shafrin publishes an influential healthcare economics and policy blog, the Healthcare Economist. The blog has won numerous awards, including Intelligent Economist’s listing of the Top 100 Economics Blogs of 2018. In this edition of High Leverage Outlier, we feature some of the blog’s policy-relevant insights.